“Pfizer (PFE) Beat The Numbers And People Just Yawned,” Says Jim Cramer

Core Insights - Pfizer Inc. reported third-quarter earnings of $16.65 billion in revenue and $0.87 in adjusted earnings per share, surpassing analyst expectations of $16.58 billion and $0.63 respectively [2] - The company raised its full-year profit per share guidance to a range of $3 to $3.15, up from the previous guidance of $2.90 to $3.10 [2] - Despite the positive earnings report and increased guidance, investor sentiment remained muted, with Jim Cramer suggesting that Pfizer needs to deliver something significant to impress investors [2][3] Financial Performance - Pfizer's third-quarter revenue was $16.65 billion, exceeding analyst estimates [2] - Adjusted earnings per share were reported at $0.87, also beating expectations [2] - The company has increased its full-year profit per share guidance to between $3 and $3.15 [2] Investor Sentiment - Jim Cramer noted that despite beating earnings expectations, the market reaction was lackluster, indicating a challenging sentiment around the stock [3] - Cramer highlighted that investors seem content with Pfizer's 7% yield, but the company needs to find a major catalyst to enhance investor interest [2][3]